Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia-Reference-Cited by-同舟云学术

Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia

Published:2011-07-19 Issue:8 Volume:134 Page:2339-2357
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

Ohlin K. Elisabet,Francardo Veronica,Lindgren Hanna S.,Sillivan Stephanie E.,O’Sullivan Sean S.,Luksik Andrew S.,Vassoler Fair M.,Lees Andrew J.,Konradi Christine,Cenci M. Angela

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/134/8/2339/13735225/awr165.pdf

Reference96 articles.

1. VEGF overexpression in the astroglial cells of rat brainstem following ozone exposure;Araneda;Neurotoxicology,2008

2. The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates–evidence from in vivo neuroimaging studies;Astradsson;Neurobiol Dis,2009

3. Glial and neuronal control of brain blood flow;Attwell;Nature,2010

4. Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian;Barcia;J Neural Transm,2005

5. 17{beta}-Estradiol Increases Astrocytic Vascular Endothelial Growth Factor (VEGF) in Adult Female Rat Hippocampus;Barouk;Endocrinology,2011

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of mGlu2/3 receptors with the orthosteric agonist LY-404,039 alleviates dyskinesia in experimental parkinsonism;Behavioural Pharmacology;2024-03-29

2. The VEGFs/VEGFRs system in Alzheimer’s and Parkinson’s diseases: Pathophysiological roles and therapeutic implications;Pharmacological Research;2024-03

3. Neurovascular coupling alteration in drug-naïve Parkinson's disease: The underlying molecular mechanisms and levodopa's restoration effects;Neurobiology of Disease;2024-02

4. Overview of Mechanisms Underlying Neuroimmune Diseases;Neuroimmune Diseases;2024

5. Levodopa-induced dyskinesia: interplay between the N-methyl-D-aspartic acid receptor and neuroinflammation;Frontiers in Immunology;2023-10-04